Dr Phuong Dinh

Clinical Senior Lecturer
Westmead Clinical School


Map

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Dinh, P., Tomasello, G., Piccart-Gebhart, M. (2010). HER2 targeted therapy. In Jatoi, I., Kaufmann, M. (Eds.), Management of Breast Diseases, (pp. 373-389). Berlin Heidelberg: Springer. [More Information]
  • Snoj, N., Dinh, P., Bedard, P., Sotiriou, C. (2009). Molecular Biology of Breast Cancer. In William B. Coleman, Gregory J. Tsongalis (Eds.), Molecular Pathology: The Molecular Basis of Human Disease, (pp. 501-517). Amsterdam, Netherlands: Elsevier.

Journals

  • Filipits, M., Dafni, U., Gnant, M., Polydoropoulou, V., Hills, M., Kiermaier, A., De Azambuja, E., Larsimont, D., Rojo, F., Viale, G., Dinh, P., et al (2018). Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: A TransHERA study. Clinical Cancer Research, 24(13), 3079-3086. [More Information]
  • Bozovic-Spasojevic, I., Azambuja, E., McCaskill-Stevens, W., Dinh, P., Cardoso, F. (2012). Chemoprevention for breast cancer. Cancer Treatment Reviews, 38(5), 329-339. [More Information]
  • Baselga, J., Bradbury, I., Eidtmann, H., Di Cosimo, S., De Azambuja, E., Aura, C., Gomez, H., Dinh, P., Fauria, K., Van Dooren, V., et al (2012). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial. The Lancet, 379(9816), 633-640. [More Information]
  • El Saghir, N., Tffayli, A., Hatoum, H., Nachef, Z., Dinh, P., Awada, A. (2011). Treatment of metastatic breast cancer: State-of-the-art subtypes and perspectives. Critical Reviews in Oncology/Hematology, 80(3), 433-449. [More Information]
  • Bedard, P., Dinh, P., Sotiriou, C., Piccart-Gebhart, M. (2009). Aiming at the target: improved adjuvant medical therapy. Breast, 18(Suppl 3), S25-S30. [More Information]
  • Colozza, M., Califano, R., Minenza, E., Dinh, P., Azambuja, E. (2008). Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women. Mini - Reviews in Medicinal Chemistry, 8(6), 564-574. [More Information]
  • Dinh, P., de Azambuja, E., Cardoso, F., Piccart-Gebhart, M. (2008). Facts and controversies in the use of trastuzumab in the adjuvant setting. Nature clinical practice. Oncology, 58(11), 645-654. [More Information]
  • Tomasello, G., de Azambuja, E., Dinh, P., Snoj, N., Piccart-Gebhart, M. (2008). Jumping higher: is it still possible? The ALTTO trial Challenge. Expert Review of Anticancer Therapy, 8(12), 1883-1890. [More Information]
  • Dinh, P., Sotiriou, C. (2008). Treatment tailoring based on molecular characterizations. Annals of Oncology, 19(Suppl 7), vii46-vii50. [More Information]

2018

  • Filipits, M., Dafni, U., Gnant, M., Polydoropoulou, V., Hills, M., Kiermaier, A., De Azambuja, E., Larsimont, D., Rojo, F., Viale, G., Dinh, P., et al (2018). Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: A TransHERA study. Clinical Cancer Research, 24(13), 3079-3086. [More Information]

2012

  • Bozovic-Spasojevic, I., Azambuja, E., McCaskill-Stevens, W., Dinh, P., Cardoso, F. (2012). Chemoprevention for breast cancer. Cancer Treatment Reviews, 38(5), 329-339. [More Information]
  • Baselga, J., Bradbury, I., Eidtmann, H., Di Cosimo, S., De Azambuja, E., Aura, C., Gomez, H., Dinh, P., Fauria, K., Van Dooren, V., et al (2012). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial. The Lancet, 379(9816), 633-640. [More Information]

2011

  • El Saghir, N., Tffayli, A., Hatoum, H., Nachef, Z., Dinh, P., Awada, A. (2011). Treatment of metastatic breast cancer: State-of-the-art subtypes and perspectives. Critical Reviews in Oncology/Hematology, 80(3), 433-449. [More Information]

2010

  • Dinh, P., Tomasello, G., Piccart-Gebhart, M. (2010). HER2 targeted therapy. In Jatoi, I., Kaufmann, M. (Eds.), Management of Breast Diseases, (pp. 373-389). Berlin Heidelberg: Springer. [More Information]

2009

  • Bedard, P., Dinh, P., Sotiriou, C., Piccart-Gebhart, M. (2009). Aiming at the target: improved adjuvant medical therapy. Breast, 18(Suppl 3), S25-S30. [More Information]
  • Snoj, N., Dinh, P., Bedard, P., Sotiriou, C. (2009). Molecular Biology of Breast Cancer. In William B. Coleman, Gregory J. Tsongalis (Eds.), Molecular Pathology: The Molecular Basis of Human Disease, (pp. 501-517). Amsterdam, Netherlands: Elsevier.

2008

  • Colozza, M., Califano, R., Minenza, E., Dinh, P., Azambuja, E. (2008). Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women. Mini - Reviews in Medicinal Chemistry, 8(6), 564-574. [More Information]
  • Dinh, P., de Azambuja, E., Cardoso, F., Piccart-Gebhart, M. (2008). Facts and controversies in the use of trastuzumab in the adjuvant setting. Nature clinical practice. Oncology, 58(11), 645-654. [More Information]
  • Tomasello, G., de Azambuja, E., Dinh, P., Snoj, N., Piccart-Gebhart, M. (2008). Jumping higher: is it still possible? The ALTTO trial Challenge. Expert Review of Anticancer Therapy, 8(12), 1883-1890. [More Information]
  • Dinh, P., Sotiriou, C. (2008). Treatment tailoring based on molecular characterizations. Annals of Oncology, 19(Suppl 7), vii46-vii50. [More Information]

To update your profile click here. For support on your academic profile contact .